Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal
  • Coronary Artery Disease
  • Diabetes Complications
  • Immunoglobulin Fab Fragments
  • Myocardial Revascularization
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Stents

abstract

  • The combination of stenting and abciximab therapy among diabetics resulted in a significant reduction in 6-month rates of death, MI, and TVR compared with stent-placebo or balloon-abciximab therapy.

publication date

  • December 21, 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10604884

Additional Document Info

start page

  • 2477

end page

  • 84

volume

  • 100

number

  • 25